-
Detailed Analysis Generate Full Report Add to Watchlist
Values as of: 2024-05-25
FSROF:OTC-FSROF (USD)
COMMON STOCK | Others |
Last Closing
USD 2Change
0.00 (0.00)%Market Cap
N/AVolume
N/AAnalyst Target
N/A![](https://ducovest.com/tools/assets/assets/images/analyst-meter.png)
N/A
Verdict
Values as of: 2024-05-25
COMMON STOCK | Others |
Last Closing
USD 2Change
0.00 (0.00)%Market Cap
N/AVolume
N/AAnalyst Target
N/AN/A
Verdict
Currency: USD
Country : USA
Symbol | Name | Price(Change) | Market Cap |
---|---|---|---|
CSTNL | iShares VII Public Limited Com.. |
N/A |
USD 32.85B |
IISHF | iShares III Public Limited Com.. |
N/A |
USD 9.10B |
ZKBGF | ZKB Gold ETF |
N/A |
USD 8.96B |
IHPCF | iShares Public Limited Company.. |
N/A |
USD 8.93B |
CUYTY | Etablissementen Franz Colruyt .. |
N/A |
USD 7.56B |
EFMSF | ETFS Metal Securities Limited .. |
N/A |
USD 7.39B |
BCYIF | iShares Public Limited Company.. |
N/A |
USD 5.80B |
IIREF | iShares Public Limited Company.. |
N/A |
USD 5.32B |
IHSXF | iShares Public Limited Company.. |
N/A |
USD 4.14B |
SSEEF | SSgA SPDR ETFs Europe I Public.. |
N/A |
USD 2.95B |
Symbol | Name | Weight | Mer | Price(Change) | Market Cap |
---|---|---|---|---|---|
IRSA:LSE | iShares MSCI South Africa.. | 8.73 % | 0.00 % |
N/A |
USD 0.06B |
IBC4:F | iShares III Public Limite.. | 8.53 % | 0.00 % |
N/A |
USD 0.06B |
IBC4:XETRA | iShares MSCI South Africa.. | 8.53 % | 0.00 % |
N/A |
USD 0.06B |
SRSA:SW | iShares MSCI South Africa.. | 8.53 % | 0.00 % |
N/A |
USD 0.05B |
EMDM | First Trust Bloomberg Eme.. | 3.73 % | 0.00 % |
N/A |
USD 5.65M |
AFK | VanEck Africa Index ETF | 3.02 % | 0.78 % |
N/A |
USD 0.04B |
EZA | iShares MSCI South Africa.. | 0.00 % | 0.59 % |
N/A |
USD 0.25B |
SRSA:LSE | iShares MSCI South Africa.. | 0.00 % | 0.00 % |
N/A |
USD 0.06B |
Market Performance vs. Industry/Classification (Others) | Market Performance vs. Exchange | ||||||
Value | Sector Median | Percentile Rank | Grade | Market Median | Percentile Rank | Grade | |
YTD | |||||||
Capital Gain | 10.50% | 74% | C | 65% | D | ||
Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
Total Return | 10.50% | 75% | C | 63% | D | ||
Trailing 12 Months | |||||||
Capital Gain | N/A | N/A | N/A | N/A | N/A | ||
Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
Total Return | N/A | N/A | N/A | N/A | N/A | ||
Trailing 5 Years | |||||||
Capital Gain | N/A | N/A | N/A | N/A | N/A | ||
Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
Total Return | N/A | N/A | N/A | N/A | N/A | ||
Average Annual (5 Year Horizon) | |||||||
Capital Gain | N/A | N/A | N/A | N/A | N/A | ||
Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
Total Return | N/A | N/A | N/A | N/A | N/A | ||
Risk Return Profile | |||||||
Volatility (Standard Deviation) | N/A | N/A | N/A | N/A | N/A | ||
Risk Adjusted Return | N/A | N/A | N/A | N/A | N/A | ||
Market Capitalization | N/A | N/A | N/A | N/A | N/A |
Target Price Action | Rating Action | Analyst | Rating | Price | Date |
---|
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.
There is nothing we particularly dislike